CPRX Catalyst Pharmaceuticals, Inc.

Fundamentals / CIK 0001369568 / USD

Catalyst Pharmaceuticals, Inc. reported $597.0M in revenue and net income of $221.3M for the trailing twelve months ended March 31, 2026 (up 5.6% year over year), with a 86.0% gross margin and a 44.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CPRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$584.1M$292.0M$0-$81.86MFY 2016 Revenue: $0FY 2016 Net Income: -$18.07M2016FY 2017 Revenue: $0FY 2017 Net Income: -$18.41M2017FY 2018 Revenue: $500KFY 2018 Net Income: -$34.00M2018FY 2019 Revenue: $102.3MFY 2019 Net Income: $31.88M2019FY 2020 Revenue: $119.1MFY 2020 Net Income: $74.98M2020FY 2021 Revenue: $140.8MFY 2021 Net Income: $39.48M2021FY 2022 Revenue: $214.2MFY 2022 Net Income: $83.08M2022FY 2023 Revenue: $398.2MFY 2023 Net Income: $71.41M2023FY 2024 Revenue: $491.7MFY 2024 Net Income: $163.9M2024FY 2025 Revenue: $589.0MFY 2025 Net Income: $214.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $589.0M $491.7M $398.2M $214.2M $140.8M $119.1M $102.3M $500K $0 $0
Cost of Revenue $87.25M $68.84M $51.97M $34.39M $21.88M $17.04M $14.76M -- -- --
Gross Profit $501.7M $422.9M $346.2M $179.8M $118.9M $102.0M $87.55M -- -- --
Research & Development $12.71M $12.65M $93.15M $19.79M $16.94M $16.50M $18.84M $19.92M $11.38M $11.37M
Selling, General & Admin $193.8M $177.7M $133.7M $57.09M $49.63M $44.23M $36.88M $15.88M -- --
Total Operating Expenses $206.5M $190.4M $226.9M $76.87M -- -- -- $35.80M $18.68M $19.28M
Operating Income $257.8M $195.1M $86.81M $101.8M $52.38M $41.30M $31.82M -$35.30M -$18.68M -$19.28M
EBITDA $295.7M $232.9M $119.7M $103.1M $52.58M $41.40M $31.88M -$35.26M -$18.63M -$19.24M
Income Before Tax $283.5M $216.3M $94.51M $104.7M $52.67M $41.89M $33.41M -$34.00M -$18.41M -$18.07M
Income Tax Expense $69.19M $52.37M $23.10M $21.64M $13.19M -$33.09M $1.53M $0 $0 $0
Net Income $214.3M $163.9M $71.41M $83.08M $39.48M $74.98M $31.88M -$34.00M -$18.41M -$18.07M
Basic EPS $1.75 $1.38 $0.67 $0.80 $0.38 $0.72 $0.31 -$0.33 -$0.21 -$0.22
Diluted EPS $1.68 $1.31 $0.63 $0.75 $0.37 $0.71 $0.30 -$0.33 -$0.21 -$0.22
Basic Shares Outstanding 122.3M 118.5M 106.3M 103.4M 103.4M 103.5M 102.9M 102.6M 85.8M 82.9M
Diluted Shares Outstanding 127.3M 124.9M 113.8M 111.4M 107.8M 106.2M 106.0M 102.6M 85.8M 82.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue $149.4M $152.6M $148.4M $146.6M $141.4M $141.8M $128.7M $122.7M
Cost of Revenue $14.47M $26.07M $22.65M $20.61M $17.91M $21.64M $19.28M $15.40M
Gross Profit $134.9M $126.5M $125.7M $125.9M $123.5M $120.2M $109.4M $107.3M
Research & Development $2.66M $1.81M $2.66M $4.36M $3.89M $3.80M $3.28M $2.98M
Selling, General & Admin $49.32M $53.42M $47.47M $45.95M $46.91M $44.19M $45.88M $40.73M
Total Operating Expenses $51.98M $55.23M $50.13M $50.31M $50.80M $47.99M $49.16M $43.72M
Operating Income $73.23M $61.85M $66.27M $66.30M $63.37M $62.84M $50.91M $54.25M
EBITDA $83.00M $71.38M $75.68M $75.76M $72.83M $72.30M $60.36M $63.68M
Income Before Tax $84.23M $71.90M $71.03M $69.29M $71.29M $74.18M $57.20M $55.79M
Income Tax Expense $20.50M $19.20M $18.25M $17.18M $14.55M $18.25M $13.32M $14.99M
Net Income $63.73M $52.70M $52.78M $52.11M $56.74M $55.94M $43.88M $40.79M
Basic EPS $0.52 -- $0.43 $0.43 $0.47 -- $0.37 $0.35
Diluted EPS $0.50 -- $0.42 $0.41 $0.45 -- $0.35 $0.33
Basic Shares Outstanding 122.3M -- 122.6M 122.2M 121.5M -- 118.9M 118.2M
Diluted Shares Outstanding 126.9M -- 127.1M 127.5M 127.0M -- 125.4M 124.7M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $709.2M $517.6M $137.6M $298.4M $171.4M $130.2M $89.51M $16.56M $57.50M $13.89M
Short-Term Investments -- -- $0 $0 $19.82M $10.04M $5.01M $36.92M $26.52M $26.51M
Cash & Short-Term Investments $709.2M $517.6M $137.6M $298.4M $191.3M $140.3M $94.52M $53.48M $84.01M $40.41M
Accounts Receivable, Net $126.5M $65.48M $53.51M $10.44M $6.62M $5.99M $10.54M $0 -- --
Inventory $37.17M $19.54M $15.64M $6.80M $7.87M $4.65M $1.96M $56K $0 --
Total Current Assets $894.0M $623.6M $219.3M $320.8M $210.1M $159.2M $111.4M $55.19M $85.19M $41.45M
Property, Plant & Equipment, Net $1.04M $1.35M $1.20M $847K $959K $130K $210K $245K $191K $244K
Intangible Assets $131.7M $156.7M $194.0M $32.47M $0 -- -- -- -- --
Long-Term Investments -- -- -- $0 $0 $0 $0 $5.01M $0 --
Total Non-Current Assets $209.9M $227.8M $250.8M $54.82M $27.68M $33.11M $1.01M $5.26M $200K $253K
Total Assets $1.10B $851.4M $470.1M $375.6M $237.8M $192.4M $112.4M $60.45M $85.39M $41.71M
Accounts Payable $11.20M $16.59M $14.79M $3.98M $2.77M $4.26M $4.12M $2.34M $1.95M $933K
Total Current Liabilities $147.2M $120.7M $76.06M $57.59M $27.06M $22.76M $24.10M $9.51M $4.27M $2.09M
Other Non-Current Liabilities $209K $315K $2.98M $14.06M $0 -- -- -- -- --
Total Non-Current Liabilities $2.56M $3.10M $6.17M $17.62M $3.89M $0 $648K $155K $157K $303K
Total Liabilities $149.7M $123.8M $82.23M $75.21M $30.96M $22.76M $24.75M $9.67M $4.42M $2.40M
Total Debt (incl. Leases) $2.79M $3.19M $3.56M $3.89M $4.20M $29K $948K -- -- --
Common Stock $123K $121K $107K $105K $103K $104K $103K $103K $103K $83K
Retained Earnings $474.2M $285.2M $121.3M $49.86M -$26.31M -$53.70M -$128.7M -$160.6M -$126.6M -$108.1M
Accumulated Other Comp. Income $0 $64K $14K $24K -$148K $31K $9.5K -$20K -- --
Total Stockholders' Equity $954.3M $727.6M $387.9M $300.4M $206.8M $169.6M $87.63M $50.78M $80.96M $39.31M
Total Equity $954.3M $727.6M $387.9M $300.4M $206.8M $169.6M $87.63M $50.78M $80.96M $39.31M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Cash & Cash Equivalents $755.9M $709.2M $689.9M $652.8M $580.7M $517.6M $442.3M $375.7M
Short-Term Investments -- -- -- -- -- -- $0 $0
Cash & Short-Term Investments $755.9M $709.2M $689.9M $652.8M $580.7M $517.6M $442.3M $375.7M
Accounts Receivable, Net $130.8M $126.5M $106.4M $65.86M $71.27M $65.48M $58.27M $57.17M
Inventory $34.93M $37.17M $28.03M $18.65M $19.78M $19.54M $20.02M $18.01M
Total Current Assets $940.4M $894.0M $852.5M $758.7M $685.7M $623.6M $539.0M $474.4M
Property, Plant & Equipment, Net $994K $1.04M $1.08M $1.15M $1.24M $1.35M $1.38M $1.23M
Intangible Assets $122.0M $131.7M $128.6M $138.0M $147.3M $156.7M $166.0M $175.4M
Total Non-Current Assets $207.2M $209.9M $199.1M $213.2M $223.2M $227.8M $233.0M $231.9M
Total Assets $1.15B $1.10B $1.05B $971.9M $908.9M $851.4M $772.0M $706.4M
Accounts Payable $7.15M $11.20M $9.10M $5.53M $11.20M $16.59M $11.56M $7.12M
Total Current Liabilities $132.4M $147.2M $128.7M $113.0M $111.6M $120.7M $105.4M $92.32M
Other Non-Current Liabilities $280K $209K $161K $309K $259K $315K $2.79M $2.40M
Total Non-Current Liabilities $2.52M $2.56M $2.62M $2.88M $2.94M $3.10M $5.67M $5.39M
Total Liabilities $134.9M $149.7M $131.4M $115.9M $114.6M $123.8M $111.1M $97.70M
Total Debt (incl. Leases) $2.68M $2.79M $2.89M $2.99M $3.09M $3.19M $3.28M $3.38M
Common Stock $122K $123K $123K $122K $122K $121K $119K $119K
Retained Earnings $523.3M $474.2M $446.8M $394.0M $341.9M $285.2M $229.2M $185.3M
Accumulated Other Comp. Income $8.0K $0 $0 $31K -$17K $64K $0 $0
Total Stockholders' Equity $1.01B $954.3M $920.2M $856.0M $794.3M $727.6M $660.9M $608.7M
Total Equity $1.01B $954.3M $920.2M $856.0M $794.3M $727.6M $660.9M $608.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $214.3M $163.9M $71.41M $83.08M $39.48M $74.98M $31.88M -$34.00M -$18.41M -$18.07M
Depreciation & Amortization $37.87M $37.77M $32.88M $1.24M $192K $92K $55K $38K $46K $43K
Stock-Based Compensation $24.78M $22.25M $14.25M $7.91M $6.07M $6.26M $3.83M $3.55M $2.41M $1.84M
Change in Receivables -$61.00M -$11.96M -$43.08M -$3.82M -$632K $4.55M -$10.54M -- -- --
Change in Inventory -$18.09M -$3.90M -$4.74M $1.06M -$3.22M -$2.69M -$1.90M -$56K -- --
Change in Payables -$5.39M $1.80M $10.82M $1.21M -$1.49M $138K $1.78M $392K $1.01M -$861K
Operating Cash Flow $208.7M $239.8M $143.6M $116.0M $60.37M $45.03M $34.61M -$26.15M -$13.74M -$17.96M
Capital Expenditure -$58K -$556K -$231K -$29K -$1.02M -$11K -$19K -$92K -- -$96K
Free Cash Flow $208.6M $239.3M $143.4M $116.0M $59.35M $45.02M $34.59M -$26.24M -- -$18.06M
Purchases of Investments -- -- -- -- -$10.00M -$10.00M -$34.73M -$36.79M -$4.0K --
Investing Cash Flow -$58K -$556K -$293.5M $9.21M -$11.02M -$5.01M $37.23M -$15.08M -$4.0K $3.55M
Common Stock Issued $0 $141.0M $0 -- -- -- -- -- $53.77M --
Share Repurchases -$25.30M $0 $0 -$6.91M -$12.09M -- -- -- -- --
Financing Cash Flow -$16.99M $140.7M -$10.86M $1.69M -$8.14M $702K $1.12M $293K $57.35M $69K
Net Change in Cash $191.6M $379.9M -$160.8M $127.0M $41.21M $40.73M $72.95M -$40.94M $43.60M -$14.34M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income $63.73M $52.70M $52.78M $52.11M $56.74M $55.94M $43.88M $40.79M
Depreciation & Amortization $9.77M $9.54M $9.42M $9.46M $9.46M $9.46M $9.45M $9.44M
Stock-Based Compensation $6.26M $5.66M $5.67M $7.60M $5.85M $5.17M $4.42M $4.41M
Change in Receivables -$4.36M -$20.07M -$40.55M $5.40M -$5.79M -$7.21M -$1.09M $3.32M
Change in Inventory $2.24M -$9.22M -$9.09M $455K -$237K $476K -$2.00M $1.94M
Change in Payables -$4.05M $2.11M $3.57M -$5.67M -$5.40M $5.03M $4.45M -$3.15M
Operating Cash Flow $59.59M $44.89M $32.44M $71.30M $60.04M $70.88M $72.87M $64.14M
Capital Expenditure -$27K -$32K $0 -$26K $0 -$88K -$259K -$10K
Free Cash Flow $59.56M $44.86M $32.44M $71.27M $60.04M $70.79M $72.61M $64.12M
Investing Cash Flow -$27K -$32K $0 -$26K $0 -$88K -$259K -$10K
Common Stock Issued -- $0 $0 $0 $0 $0 $0 $0
Share Repurchases -$14.57M -- -- -- -- -- -- --
Financing Cash Flow -$12.87M -$25.58M $4.65M $872K $3.06M $4.43M -$5.97M $1.16M
Net Change in Cash $46.69M $19.28M $37.09M $72.14M $63.10M $75.22M $66.64M $65.28M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 85.2% 86.0% 86.9% 83.9% 84.5% 85.7% 85.6% -- -- --
Operating Margin 43.8% 39.7% 21.8% 47.5% 37.2% 34.7% 31.1% -7059.0% -- --
Net Profit Margin 36.4% 33.3% 17.9% 38.8% 28.0% 63.0% 31.2% -6800.7% -- --
Return on Equity (ROE) 22.5% 22.5% 18.4% 27.7% 19.1% 44.2% 36.4% -67.0% -22.7% -46.0%
Return on Assets (ROA) 19.4% 19.2% 15.2% 22.1% 16.6% 39.0% 28.4% -56.3% -21.6% -43.3%
Current Ratio 6.08x 5.17x 2.88x 5.57x 7.76x 7.00x 4.62x 5.80x 19.97x 19.79x
Quick Ratio 5.82x 5.01x 2.68x 5.45x 7.47x 6.79x 4.54x 5.80x 19.97x 19.29x
Debt to Equity 0.00x 0.00x 0.01x 0.01x 0.02x 0.00x 0.01x -- -- --
Revenue Growth (YoY) +19.8% +23.5% +85.9% +52.1% +18.3% +16.4% +20361.3% -- -- --
Gross Profit Growth (YoY) +18.6% +22.1% +92.6% +51.2% +16.6% +16.5% -- -- -- --
Operating Income Growth (YoY) +32.1% +124.8% -14.8% +94.4% +26.8% +29.8% -- -- -- --
Net Income Growth (YoY) +30.8% +129.5% -14.0% +110.4% -47.3% +135.2% -- -- -- --
EPS Growth (YoY) +26.8% +106.0% -16.2% +110.5% -47.2% +132.3% -- -- -- --
Operating Cash Flow Growth (YoY) -13.0% +67.0% +23.7% +92.2% +34.1% +30.1% -- -- -- --
Free Cash Flow Growth (YoY) -12.8% +66.9% +23.6% +95.5% +31.8% +30.2% -- -- -- --
5Y Revenue / Share Growth +318.7% +317.7% +76808.8% -- -- -- -- -- -- --
5Y Net Income / Share Growth +141.9% +346.8% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Gross Margin 86.0% 85.2% 85.7% 85.8% 86.1% 86.0% 86.3% 86.7%
Operating Margin 44.8% 43.8% 44.8% 43.6% 43.3% 39.7% 37.8% 19.8%
Net Profit Margin 37.1% 36.4% 37.6% 37.4% 36.9% 33.3% 31.0% 15.7%
Return on Equity (ROE) 21.9% 22.5% 23.6% 24.4% 24.8% 22.5% 21.6% 11.2%
Return on Assets (ROA) 19.3% 19.4% 20.7% 21.5% 21.7% 19.2% 18.5% 9.6%
Current Ratio 7.10x 6.08x 6.62x 6.71x 6.14x 5.17x 5.11x 5.14x
Quick Ratio 6.84x 5.82x 6.40x 6.55x 5.96x 5.01x 4.92x 4.94x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x
Revenue Growth (YoY) +5.6% +7.6% +15.3% +19.4% +43.6% +28.3% +25.3% +23.2%
Gross Profit Growth (YoY) +9.2% +5.3% +14.9% +17.4% +43.6% +26.8% +23.6% +22.6%
Operating Income Growth (YoY) +15.6% -1.6% +30.2% +22.2% +133.6% +50.7% -- +16.2%
Net Income Growth (YoY) +12.3% -5.8% +20.3% +27.7% +143.8% +60.5% -- +8.0%
EPS Growth (YoY) +10.6% -- +16.2% +22.9% +135.0% -- -- -2.8%
Operating Cash Flow Growth (YoY) -0.8% -36.7% -55.5% +11.2% +88.1% +27.4% +61.5% +108.5%
Free Cash Flow Growth (YoY) -0.8% -36.6% -55.3% +11.1% +89.3% +27.4% +61.1% +108.5%
Source: SEC EDGAR CompanyFacts (CIK 0001369568) · from December 31, 2002 Data through March 31, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal